ArticleCell reports. Medicine2024

Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy.

Shijie Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.